 |
PDBsum entry 2pe0
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.11.1
- non-specific serine/threonine protein kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
|
|
2.
|
L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
|
|
 |
 |
 |
 |
 |
L-seryl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
L-threonyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Bioorg Med Chem Lett
17:3814-3818
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 1: design, synthesis and biological activity.
|
|
I.Islam,
J.Bryant,
Y.L.Chou,
M.J.Kochanny,
W.Lee,
G.B.Phillips,
H.Yu,
M.Adler,
M.Whitlow,
E.Ho,
D.Lentz,
M.A.Polokoff,
B.Subramanyam,
J.M.Wu,
D.Zhu,
R.I.Feldman,
D.O.Arnaiz.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
HTS screening identified 1 with micromolar inhibitory activity against PDK1.
Optimization of 1 afforded 4i (BX-517) which has single-digit nanomolar activity
against PDK1 and excellent selectivity against PKA.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
D.A.Erlanson,
J.W.Arndt,
M.T.Cancilla,
K.Cao,
R.A.Elling,
N.English,
J.Friedman,
S.K.Hansen,
C.Hession,
I.Joseph,
G.Kumaravel,
W.C.Lee,
K.E.Lind,
R.S.McDowell,
K.Miatkowski,
C.Nguyen,
T.B.Nguyen,
S.Park,
N.Pathan,
D.M.Penny,
M.J.Romanowski,
D.Scott,
L.Silvian,
R.L.Simmons,
B.T.Tangonan,
W.Yang,
and
L.Sun
(2011).
Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discovery.
|
| |
Bioorg Med Chem Lett,
21,
3078-3083.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
K.Kaur,
and
T.T.Talele
(2009).
Structure-based CoMFA and CoMSIA study of indolinone inhibitors of PDK1.
|
| |
J Comput Aided Mol Des,
23,
25-36.
|
 |
|
|
|
|
 |
C.Garcia-Echeverria,
and
W.R.Sellers
(2008).
Drug discovery approaches targeting the PI3K/Akt pathway in cancer.
|
| |
Oncogene,
27,
5511-5526.
|
 |
|
|
|
|
 |
C.Peifer,
and
D.R.Alessi
(2008).
Small-molecule inhibitors of PDK1.
|
| |
ChemMedChem,
3,
1810-1838.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |